Stockscreener 앱 받기
49.14
4.64%
2.18
시장 영업 전:
49.38
0.24
+0.49%
전일 마감가:
$46.96
열려 있는:
$47.9
하루 거래량:
4.77M
Relative Volume:
0.91
시가총액:
$8.78B
수익:
$1.27B
순이익/손실:
$-245.03M
주가수익비율:
-34.92
EPS:
-1.4071
순현금흐름:
$-245.36M
1주 성능:
-3.42%
1개월 성능:
-14.23%
6개월 성능:
-41.59%
1년 성능:
-4.30%
1일 변동 폭
$47.60
$49.98
1주일 범위
$46.13
$51.98
52주 변동 폭
$36.22
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
명칭
Tempus Ai Inc
전화
800-976-5448
주소
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, MMED
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
49.14 | 8.40B | 1.27B | -245.03M | -245.36M | -1.4071 |
VEEV
Veeva Systems Inc
|
185.23 | 30.26B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
42.10 | 7.92B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
81.64 | 6.84B | 1.31B | 215.20M | 408.32M | 2.4627 |
MMED
Minimed Group Inc
|
17.10 | 4.65B | 0 | 0 | 0 | 0.00 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-19 | 개시 | Mizuho | Outperform |
| 2026-02-17 | 개시 | Robert W. Baird | Outperform |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-10-21 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-10-20 | 개시 | Canaccord Genuity | Buy |
| 2025-09-02 | 개시 | H.C. Wainwright | Buy |
| 2025-04-21 | 개시 | BTIG Research | Buy |
| 2025-02-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-02-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | 재개 | TD Cowen | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-12-09 | 개시 | Guggenheim | Buy |
| 2024-11-11 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-10-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-12 | 개시 | Piper Sandler | Neutral |
| 2024-07-09 | 개시 | BofA Securities | Buy |
| 2024-07-09 | 개시 | JP Morgan | Overweight |
| 2024-07-09 | 개시 | Longbow | Buy |
| 2024-07-09 | 개시 | Loop Capital | Buy |
| 2024-07-09 | 개시 | Morgan Stanley | Overweight |
| 2024-07-09 | 개시 | Needham | Buy |
| 2024-07-09 | 개시 | Stifel | Buy |
| 2024-07-09 | 개시 | TD Cowen | Buy |
| 2024-07-09 | 개시 | William Blair | Outperform |
모두보기
Tempus Ai Inc 주식(TEM)의 최신 뉴스
Tempus AI Inc. (TEM) Touted as a Buy Amid Focus on Healthcare Opportunities - Insider Monkey
Promising Artificial Intelligence Stocks To Follow NowMarch 23rd - MarketBeat
Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story - Yahoo Finance Singapore
Best Artificial Intelligence Stocks Worth WatchingMarch 22nd - MarketBeat
Top Artificial Intelligence Stocks To ResearchMarch 21st - MarketBeat
Market Moves: What is the next catalyst for Tempus AI Inc2026 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
HC Wainwright raises Tempus AI (TEM) price target to $95 - MSN
H.C. Wainwright Raises Tempus AI (TEM) Price Target to $95 - Insider Monkey
Top Artificial Intelligence Stocks To ConsiderMarch 20th - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
10 Best New AI Stocks to Buy - Insider Monkey
Artificial Intelligence Stocks To ConsiderMarch 19th - MarketBeat
JPMorgan lowers Tempus AI (TEM) PT to $80, maintains neutral rating - MSN
Mizuho initiates coverage of Tempus AI (TEM) with outperform recommendation - MSN
3 MedTech stocks poised to gain in 2026 from the AI boom - MSN
Tempus AI Pediatric Leukemia Registry Deepens Oncology Data And Patient Reach - Yahoo Finance Singapore
Tempus AI, Inc. (TEM) announces strategic deal with Merck to fast-track AI-driven precision medicine - MSN
Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Weakness? - Yahoo Finance
Promising Artificial Intelligence Stocks To Keep An Eye OnMarch 17th - MarketBeat
Is Tempus AI (TEM) The Best AI Healthcare Stock in Cathie Wood’s Portfolio? - Insider Monkey
Tempus and Blood Cancer United announce collaboration to develop one of the largest pediatric acute myeloid leukemia Real-World Data registries - marketscreener.com
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries - The AI Journal
Best Artificial Intelligence Stocks To Add to Your WatchlistMarch 16th - MarketBeat
Tempus AI Advances Clinical Applications and Healthcare Software - TradingView
Bamco Inc. NY Increases Stake in Tempus AI, Inc. - National Today
Tempus AI, Inc. $TEM Shares Bought by Bamco Inc. NY - MarketBeat
Why Tempus AI, Inc. (TEM) Went Down On Wednesday - MSN
Cathie Wood buys $2 million of tumbling AI stock - MSN
Best Artificial Intelligence Stocks To Follow NowMarch 15th - MarketBeat
Clear Street Group Inc. Acquires Stake in Tempus AI - National Today
Casdin Capital LLC Purchases Shares of 294,127 Tempus AI, Inc. $TEM - MarketBeat
Clear Street Group Inc. Acquires Shares of 716,406 Tempus AI, Inc. $TEM - MarketBeat
Artificial Intelligence Stocks Worth WatchingMarch 14th - MarketBeat
Tempus AI falls despite Q4 beats, 2026 revenue guidance above consensus - MSN
Tempus AI price target lowered to $80 from $85 at JPMorgan - MSN
Top Artificial Intelligence Stocks To Watch NowMarch 13th - MarketBeat
Tempus AI, Inc. $TEM Shares Acquired by Landscape Capital Management L.L.C. - MarketBeat
Tempus AI, Inc. Class A Trade Ideas — BX:TEM - TradingView
Tempus AI, Inc. $TEM Shares Acquired by BNP Paribas Financial Markets - MarketBeat
Tempus AI’s Ambry Genetics Leads with Validated 99.5% Accurate Hereditary Cancer Risk Assessment Tool - MSN
Assessing Tempus AI (TEM) Valuation As New Oncology Study Highlights Clinical Impact Of Its AI Platform - simplywall.st
Tempus AI Inc (TEM) Shares Down 5.14% on Mar 12 - GuruFocus
Tempus AI Expands Clinical Validation of AI-Powered Cancer Diagnostics - Yahoo Finance
First Trust Advisors LP Has $47.63 Million Position in Tempus AI, Inc. $TEM - MarketBeat
Cathie Wood’s ARK sells LY Corp stock, buys Tempus AI - Investing.com
Tempus AI Earnings Call Highlights Strong Growth Path - The Globe and Mail
Tempus AI Broadens Clinical Assessment of AI-Driven Cancer Diagnostic Tools - Bitget
Promising Artificial Intelligence Stocks To Follow TodayMarch 11th - MarketBeat
Why Tempus AI Stock Is Up Wednesday?Tempus AI (NASDAQ:TEM) - Benzinga
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings - Business Wire
Tempus AI's (TEM) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Tempus Ai Inc (TEM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.16%
자본화:
|
볼륨(24시간):